|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| A61P 37/06 | |||
| A61K 35/17 | |||
| A61K 35/12 | |||
| A61K 38/17 |
| (11) | Number of the document | 2872184 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13816739.0 |
| Date of filing the European patent application | 2013-07-12 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/050293 |
| Date | 2013-07-12 |
| (87) | Number | WO 2014/012001 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261671508 P | 2012-07-13 | US |
| (72) |
LEVINE, Bruce, L., US
KALOS, Michael, D., US
JUNE, Carl, H., US
|
| (73) |
The Trustees of The University of Pennsylvania,
Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283,
US
|
| (54) | CART19 FOR USE IN A METHOD TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE |
| CART19 FOR USE IN A METHOD TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE |